![Matthias Will](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Matthias Will
Företagsledare/Principal på
AUTOLUS THERAPEUTICS PLC
Förmögenhet: - $ per 2026-05-31
Profil
Matthias Will currently works at Autolus Therapeutics Plc, as Chief Development Officer from 2024.
Dr. Will also formerly worked at Dren Bio, Inc., as Chief Medical Officer, CytomX Therapeutics, Inc., as Head-Clinical Development, and CRISPR Therapeutics, Inc., as Vice President-Clinical Development Officer.
Dr. Will received his graduate degree from Hannover Medical School.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-03-18 | 0 ( -.--% ) | - $ | 2026-05-31 |
Aktiva positioner av Matthias Will
| Företag | Position | Start |
|---|---|---|
| AUTOLUS THERAPEUTICS PLC | Företagsledare/Principal | 2024-09-30 |
Tidigare kända positioner av Matthias Will
| Företag | Position | Slut |
|---|---|---|
CRISPR Therapeutics, Inc.
 CRISPR Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops gene based medicines for the treatment of human diseases | Företagsledare/Principal | - |
| CYTOMX THERAPEUTICS, INC. | Teknisk/Vetenskaplig/F&U Direktör | - |
Dren Bio, Inc.
 Dren Bio, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops antibody therapeutics for cancer, autoimmune and neurology | Teknisk/Vetenskaplig/F&U Direktör | - |
Matthias Wills utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
3
Första gradens relationer
5
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 5 |
|---|---|
Hannover Medical School
 Hannover Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CytomX Therapeutics, Inc.
 CytomX Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as an oncology-base biopharmaceutical company, which focuses on developing probody therapeutics for the treatment of cancer | Health Technology |
CRISPR Therapeutics, Inc.
CRISPR Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops gene based medicines for the treatment of human diseases | Health Technology |
Autolus Therapeutics Plc
 Autolus Therapeutics Plc Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of gene therapies | Health Technology |
Dren Bio, Inc.
Dren Bio, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops antibody therapeutics for cancer, autoimmune and neurology | Health Technology |
